Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.68 per share, beating the Zacks Consensus Estimate of$ 1.62 per share. This compares to earnings of $1.62 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.70%. A quarter ago, it was expected that this specialty pharmaceutical company would post earnings of$ 1.43 per share when it actually produced earnings of $1.49, delivering a surprise of +4.2%.Over the ...